The fear of contracting COVID-19 keeps many Americans from venturing outside their homes, especially if they can avoid it. Drug delivery companies and the now widespread availability of delivery options offered by retail and locally owned pharmacies is making patients feel they have a safer option.
Mail-order prescriptions increased 21 percent from last year during the last week of March, now taking up 5.8 percent of the total prescription drug market share. Retail pharmacy giant CVS reported a 10-fold increase in prescription deliveries after eliminating fees in early March, The Wall Street Journal reported.
This trend is not expected to go away after the pandemic. This is especially true among younger patients, who have fewer prescriptions and are used to purchasing online.
More articles on pharmacy:
Drugmakers forced to reshape sales strategy amid pandemic
NIH to test remdesivir in combo with Eli Lilly arthritis drug
Regeneron says its COVID-19 antibody drug could be ready by fall
NIH to test remdesivir in combo with Eli Lilly arthritis drug
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.